Hadassah

Hadassah Participates in Worldwide Breakthrough of Genetic Links to Diabetes

Wednesday, Nov 16 2016

. “When we started working on this, almost two decades ago,” Prof. Glaser relates, “we naively thought that we could find the genetic cause of diabetes by studying a thousand individuals using a few hundred genetic markers."

More than 300 scientists from 22 countries, including the Hadassah Medical Organization’s Prof. Benjamin Glaser, have found that most of the genetic risk for developing type 2 diabetes can be attributed to common, shared differences in the genetic code, each of which contributes a small amount to an individual’s risk of disease.

For over the last 15 years, Prof. Glaser has led the Middle East charge on type 2 diabetes and its genetics. “When we started working on this, almost two decades ago,” he relates, “we naively thought that we could find the genetic cause of diabetes by studying a thousand individuals using a few hundred genetic markers. We now know that we need to study hundreds of thousands of individuals, using millions of genetic markers, just to begin to understand the genetics of this common and devastating disease. It has been a true honor to be among the world’s best in such a ground-breaking study.”

The research, which involved a comprehensive investigation of the underlying genetic architecture of type 2 diabetes, unveils the most detailed, unprecedented look at genetic differences that heighten a person’s risk for development of the disease. It also identifies several promising targets for new treatments. As the researchers explain, they found over a dozen genes in affected participants where changes in the DNA sequence altered the structure or composition of the proteins they encode, suggesting that those genes and proteins are directly involved in the development of the disease. By the same token, these changes provide important clues as to the mechanism by which they confer risk. Understanding the possible mechanism, in turn, provides possible clues to new drug targets.

Given these genetic findings, the researchers suggest that any personalized approach to treatment and prevention of type 2 diabetes needs to be tailored on the basis of an individual’s broader genetic profile, as well as environmental factors.

Highlighted in the July 11, 2016 online issue of Nature, the study was led by researchers at the University of Michigan School of Public Health, the Welcome Trust Center for Human Genetics at the University of Oxford, the Broad Institute of Massachusetts Institute of Technology and Harvard Medical Center, and Massachusetts General Hospital. DNA from 120,000 individuals was examined to pinpoint genes and their variants which influence diabetes, yielding the more complete picture of the number and characteristics of the genetic variants.

Head of Research and Development at Hadassah, Prof. Eyal Mishani, notes that “the collaborative nature of such a project demonstrates the power of the masses and paves the way for many exciting advances in human medicine.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 20 2017

Drug May Prevent Recurrence of Aggressive Cancer

An international team led by Hadassah Hospital Oncologist Dr. Amir Sonnenblick reveals that giving a drug called metformin to diabetic women with a particularly aggressive form of breast cancer may prevent its recurrence.

READ MORE ›
alt_text

Tuesday, Jun 20 2017

Rising Genetics Star Receives Prestigious Award

Hadassah Hospital Geneticist Dr. Tamar Harel, who is looking into the underlying genetic reasons for rare diseases in children, has received an award from Partners HealthCare Personalized Medicine (PHPM), affiliated with Harvard Medical School, Boston Children’s, Brigham and Women’s, and Massachusetts General hospitals.

READ MORE ›
alt_text

Monday, Jun 19 2017

Women's Health Empowerment Summit: A Success

Attendees from coast to coast came together to learn, network, and identify strategic next steps for improving and protecting women's health at the Coalition for Women's Health Equity's Women's Health Empowerment Summit, convened by Hadassah.

READ MORE ›
alt_text

Monday, Jun 19 2017

A Call To Action from the Women's Health Empowerment Summit

The Coalition for Women’s Health Equity’s inaugural Women’s Health Empowerment Summit was a resounding success! In 2016, Hadassah founded the Coalition for Women's Health Equity -- a broad coalition of 23 women's and health organizations that promotes policies to address inequities in quality of care, funding and support, and gaps in women's health awareness.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More